Rohto Pharmaceutical Co Ltd (4527) – Strategy, SWOT and Corporate Finance Report

Rohto Pharmaceutical Co Ltd (4527) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Rohto Pharmaceutical Co Ltd (Rohto Pharmaceutical) manufactures and markets pharmaceutical products, cosmetics, and functional foods. The company offers products for eye care, skincare, internal medicine, and other diseases. Under eye care products, the company offers eye drops, contact lenses, and eyewash. Under skincare products, the company offers face wash, lotions, creams, medicine, and medicated products. It also offers medicines for internal use such as digestive products and herbal medicine. It has manufacturing and research laboratories in Iga, Osaka, and Kyoto. The company has offices and branches in Osaka, Tokyo, Nagoya, Sapporo, Fukuoka, Sendai, and Hiroshima. Rohto Pharmaceutical is headquartered in Osaka, Japan.

Scope

• Detailed information on Rohto Pharmaceutical Co Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Rohto Pharmaceutical Co Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Rohto Pharmaceutical Co Ltd including a breakdown and examination of key business segments

• News about Rohto Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Rohto Pharmaceutical Co Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Rohto Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Rohto Pharmaceutical Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Towa Pharmaceutical Co Ltd

Taisho Pharmaceutical Holdings Co Ltd

Shionogi & Co Ltd

Otsuka Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

Chugai Pharmaceutical Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Rohto Pharmaceutical Co Ltd - Key Facts

Rohto Pharmaceutical Co Ltd - Key Employees

Rohto Pharmaceutical Co Ltd - Key Employee Biographies

Rohto Pharmaceutical Co Ltd - Major Products and Services

Rohto Pharmaceutical Co Ltd - History

Rohto Pharmaceutical Co Ltd - Company Statement

Rohto Pharmaceutical Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Rohto Pharmaceutical Co Ltd - Business Description

Product Category: Eye Care Products

Overview

Performance

Product Category: Internal Medicines and Food

Overview

Performance

Product Category: Others

Overview

Performance

Product Category: Skincare Products

Overview

Performance

Geographical Segment: America

Performance

Geographical Segment: Asia

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Japan

Performance

Geographical Segment: Other

Performance

R&D Overview

Rohto Pharmaceutical Co Ltd - Corporate Strategy

Rohto Pharmaceutical Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Rohto Pharmaceutical Co Ltd - Strengths

Rohto Pharmaceutical Co Ltd - Weaknesses

Rohto Pharmaceutical Co Ltd - Opportunities

Rohto Pharmaceutical Co Ltd - Threats

Rohto Pharmaceutical Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Rohto Pharmaceutical Co Ltd, Recent Deals Summary

Section 4 – Company’s Recent Developments

Nov 12, 2020: Rohto Pharmaceutical announces Finance Financial Results for the Second Quarter of the Fiscal Year Ending March 2021

Aug 11, 2020: Rohto Pharmaceutical announces first and fourth half of the financial statements for the period of March 2021

Section 5 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Rohto Pharmaceutical Co Ltd, Key Facts

Rohto Pharmaceutical Co Ltd, Key Employees

Rohto Pharmaceutical Co Ltd, Key Employee Biographies

Rohto Pharmaceutical Co Ltd, Major Products and Services

Rohto Pharmaceutical Co Ltd, History

Rohto Pharmaceutical Co Ltd, Other Locations

Rohto Pharmaceutical Co Ltd, Subsidiaries

Rohto Pharmaceutical Co Ltd, Key Competitors

Rohto Pharmaceutical Co Ltd, Ratios based on current share price

Rohto Pharmaceutical Co Ltd, Annual Ratios

Rohto Pharmaceutical Co Ltd, Annual Ratios (Cont…1)

Rohto Pharmaceutical Co Ltd, Annual Ratios (Cont…2)

Rohto Pharmaceutical Co Ltd, Interim Ratios

Rohto Pharmaceutical Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Rohto Pharmaceutical Co Ltd, Performance Chart (2017 – 2021)

Rohto Pharmaceutical Co Ltd, Ratio Charts

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2745

Saved reports